Japan· JP-4291019M1023
サリドマイド
A medicinal product containing サリドマイド, registered in Japan by 藤本製薬, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- サリドマイド
- Manufacturer
- 藤本製薬
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
サリドマイド in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomMyrin 100mg tabletsLipomed GmbH
- United StatesThalomidCelgene Corporation
- NetherlandsThalidomide BMS 50 mg harde capsulesBristol-Myers Squibb Pharma EEIG
- SwedenThalidomide BMS 50 mg Kapsel, hårdBristol-Myers Squibb Pharma EEIG
- PolandThalidomide AccordAccord Healthcare Polska Sp. z o.o.
- FranceTHALIDOMIDE ACCORD 50 mg, géluleACCORD HEALTHCARE FRANCE
- BelgiumThalidomide BMS 50 mgBristol-Myers Squibb Pharma
- IcelandThalidomide BMSBristol-Myers Squibb Pharma EEIG*
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Cyprus · Thalidomide Accord
- Germany · Thalidomid Zentiva
- Denmark · Thalidomid Accord, Thalidomide Zentiva
- Spain · Taliodmida Accord
- France · Thalidomide Accord, Thalidomide Koanaa
- United Kingdom (Northern Ireland) · Thalidomide Accord-Uk, Thalidomide Eugia (Uk)
- Hungary · Thalidomide Accord
- Iceland · Thalidomide Bms
- Italy · Talidomide Accord, Talidomide Aurobindo
- Liechtenstein · Thalidomide Bms
- Malta · Thalidomide Accord
- Netherlands · Thalidomide, Thalidomide Milstein
- Norway · Thalidomide Bms, Thalidomide Zentiva
- Portugal · Talidomida Accord, Talidomida Generis
- Romania · Talidomidă Accord
- Sweden · Thalidomide Zentiva
- Slovenia · Talidomid Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a6f34e64-0cc3-426d-9776-a3327f05c052 GET /v1/drugs/a6f34e64-0cc3-426d-9776-a3327f05c052?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１００ｍｇ１カプセル",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "4291019M1023",
"category": "内用薬",
"price_yen": 6883.3,
"generic_name": "サリドマイド",
"product_name_jp": null,
"therapeutic_class": "4291",
"transitional_expiry": null
}See everything about サリドマイド.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.